Discontinuation of Antibiotic Susceptibility Testing on Enterococcus Faecalis Positive Urine Cultures in Hospitalized Patients: an Impact on Antibiotic Prescriptions? (FaecaCible)
NCT05743192 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 217
Last updated 2023-06-15
Summary
The objective of the study is to evaluate the impact of not reporting antibiotic susceptibility tests on antibiotic consumption for Enterococcus faecalis positive urine cultures in adult hospitalized patients. The secondary objectives are to evaluate the impact of this intervention on antibiotic prescription rates as well as on antibiotic consumption according to: patient gender, type of antibiotic therapy (probabilistic/documented) and diagnosis (urinary tract infection or colonization). It is hypothesized that antibiotic consumption is lower after the application of the absence of antibiotic susceptibility reporting compared to before.
Conditions
- Antibiotic Susceptibility Reporting
Interventions
- OTHER
-
Stop performing an antibiotic susceptibility test
Intervention = Stop performing an antibiotic susceptibility test for enterococcus faecalis in urine cultures. It defines two groups : one before and one after the intervention
Sponsors & Collaborators
-
Central Hospital, Nancy, France
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-02-15
- Primary Completion
- 2023-06-08
- Completion
- 2023-06-08
Countries
- France
Study Locations
More Related Trials
-
Resistant Bacteria in Children in France
NCT06036628 ·Status: COMPLETED
-
Treatment of Enterococcus Faecalis Bacterem
NCT07299539 ·Status: RECRUITING
-
Population Pharmacokinetic Study of Colistin in Patients Infected With Multiresistant Gram-negative Bacteria
NCT01060891 ·Status: COMPLETED ·Phase: PHASE1
-
NCCR AntiResist:: New Approaches to Combat Antibiotic-resistant Bacteria
NCT05017766 ·Status: RECRUITING
-
Subcutaneous Daptomycin in Healthy Volunteers (DAPTOSC)
NCT04434300 ·Status: COMPLETED ·Phase: PHASE1
-
Fosfomycin I.v. for Treatment of Severely Infected Patients
NCT02979951 ·Status: RECRUITING
-
Predictors of Rates of Resistant Gram-Negative Bacteria
NCT01075009 ·Status: COMPLETED
-
Evaluation of the Non-inferiority of Cefoxitin Versus Imipenem/Cilastatin in the Treatment of Urinary Tract Infections Caused by ESBL-producing Escherichia Coli
NCT02474706 ·Status: TERMINATED ·Phase: PHASE4
-
Quinolone Resistance in Bloodstream Isolates of Escherichia Coli
NCT00449735 ·Status: COMPLETED
-
Randomized Trial of Culture Directed Versus Empiric Antibiotics for Urinary Tract Infections in Older Women
NCT05726318 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Impact of Fluoroquinolone Resistance in Bacteremia Caused by Gram-Negative Bacilli of Urinary Tract Origin
NCT00414362 ·Status: COMPLETED
-
Fosfomycin Versus Meropenem or Ceftriaxone in Bacteriemic Infections Caused by Multidrug Resistance in E.Coli
NCT02142751 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacological Study of High Doses of Ceftriaxone in Meningitidis
NCT01745679 ·Status: COMPLETED ·Phase: PHASE4
-
Detection of Clindamycin Resistance Antibiotic Genes Among Staphylococcus Isolates by Using Real Time PCR
NCT04933019 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Safety and Efficacy Study of Ceftaroline in Subjects With Staphylococcus Aureus Bacteremia or With Persistent Methicillin-Resistant Staphylococcus Aureus Bacteremia
NCT01701219 ·Status: COMPLETED ·Phase: PHASE4
-
The Role of Guideline-adherent Perioperative Antibiotic Administration and the Risk of Surgical Site Infections After Non-cardiac Surgery.
NCT03982810 ·Status: WITHDRAWN
-
A Placebo-Controlled, Dose-Escalating Study to Examine the Safety and Tolerability of Single Intravenous Doses of CF-301 in Healthy Subjects
NCT02439359 ·Status: COMPLETED ·Phase: PHASE1
-
Immunosuppression and Intensive Care Unit-acquired Multidrug-resistant Bacteria
NCT06652126 ·Status: RECRUITING
-
Antibiotic Outbreak, Risk Factors for Never Event, Prediction of Inappropriate Use
NCT03489330 ·Status: COMPLETED
-
Ceftobiprole in the Treatment of Hospitalized Patients With Staphylococcus Aureus Bacteremia
NCT00505258 ·Status: WITHDRAWN ·Phase: PHASE2
-
Trial for the Treatment of Extensively Drug-Resistant Gram-negative Bacilli (OVERCOME)
NCT01597973 ·Status: COMPLETED ·Phase: PHASE3
-
Modified Reporting From Indwelling Catheters
NCT03488355 ·Status: COMPLETED ·Phase: NA
-
Vancomycin Study: Treatment of Catheter Related Bloodstream Infection Caused by Coagulase Negative Staphylococcus
NCT00175370 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety Study of Short-term Antibiotic for Pyelonephritis in Women
NCT01390623 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of Plasma Levels of Colistin in Patients With Carbapenem Resistant Acinetobacter Baumannii Infection
NCT02482961 ·Status: COMPLETED